Abraham N. Oler

This profile gathers the share dealings of Abraham N. Oler in Traws Pharma, Inc., where the filings describe the role as board member. Between 28 September 2021 and 28 January 2022, the trades on record add up to 7 filings.

On the market, this insider has only ever bought: 6 purchases, €22k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. So far in 2022, the count stands at 4 purchases and no sales.

Half of the purchases are above €2,830 and half below. Clusters matter here: 1 out of 6 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 31 January 2022, reports an open-market purchase of €2,247 in Traws Pharma, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.